{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:30:24Z","timestamp":1789122624085,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2024\/03\/31553"],"award-info":[{"award-number":["PSAU\/2024\/03\/31553"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00335-026-10218-3","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:36:20Z","timestamp":1775039780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrative immunogenomic and experimental characterization reveals CXCL9, CXCL13, CCL5 and CD74 as key oncogenic drivers in breast cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Mohammed A.","family":"Alshehri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"3","key":"10218_CR1","first-page":"287","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ji Y, Liu S, Li J, Wu J, Jin Q et al (2025) Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J Natl Cancer Cent 5(3):287","journal-title":"J Natl Cancer Cent"},{"issue":"1","key":"10218_CR2","doi-asserted-by":"publisher","first-page":"9347","DOI":"10.1038\/s41598-025-93883-9","volume":"15","author":"Y Cai","year":"2025","unstructured":"Cai Y, Dai F, Ye Y, Qian J (2025) The global burden of breast cancer among women of reproductive age: a comprehensive analysis. Sci Rep 15(1):9347","journal-title":"Sci Rep"},{"key":"10218_CR3","doi-asserted-by":"publisher","first-page":"1586497","DOI":"10.3389\/fpubh.2025.1586497","volume":"13","author":"S Jian","year":"2025","unstructured":"Jian S, Tang Y, Yao G (2025) Breast cancer burden (1990\u20132040) in individuals aged 55 and above: a GBD 2021 analysis of global trends, sex-specific risk factors, and intervention impact. Front Public Health 13:1586497","journal-title":"Front Public Health"},{"key":"10218_CR4","doi-asserted-by":"crossref","unstructured":"Ye F, Chen X, Cao Y, You Z, Lai J (2025) The global, regional, and national disease burden of breast cancer attributable to behavioral risks from 1990 to 2021 and projections to 2035: a systematic analysis of the Global Burden of Disease Study 2021. Breast Cancer. :1\u201314","DOI":"10.1007\/s12282-025-01771-x"},{"issue":"1","key":"10218_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng L-W, Ding Y, Chen Y-F, Cai Y-W, Wang L-P et al (2025) Breast cancer: pathogenesis and treatments. Signal Transduct Target therapy 10(1):49","journal-title":"Signal Transduct Target therapy"},{"key":"10218_CR6","doi-asserted-by":"publisher","first-page":"1630464","DOI":"10.3389\/fonc.2025.1630464","volume":"15","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Zhou Q (2025) Immunotherapy resistance in triple-negative breast cancer: molecular mechanisms, tumor microenvironment, and therapeutic implications. Front Oncol 15:1630464","journal-title":"Front Oncol"},{"issue":"3","key":"10218_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41571-024-00984-x","volume":"22","author":"M Lopez de Rodas","year":"2025","unstructured":"Lopez de Rodas M, Villalba-Esparza M, Sanmamed MF, Chen L, Rimm DL, Schalper KA (2025) Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach. Nat Reviews Clin Oncol 22(3):163\u2013181","journal-title":"Nat Reviews Clin Oncol"},{"key":"10218_CR8","doi-asserted-by":"publisher","first-page":"1610998","DOI":"10.3389\/fimmu.2025.1610998","volume":"16","author":"H Xue","year":"2025","unstructured":"Xue H, Fan Y, Li Y, Zhao Q, Zhang X, Zhao P et al (2025) Tumor-infiltrating lymphocytes in NSCLC: from immune surveillance to immunotherapy. Front Immunol 16:1610998","journal-title":"Front Immunol"},{"issue":"1","key":"10218_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-025-03765-3","volume":"25","author":"Y Lv","year":"2025","unstructured":"Lv Y, Chen C, Han M, Tian C, Song F, Feng S et al (2025) CXCL2: a key player in the tumor microenvironment and inflammatory diseases. Cancer Cell Int 25(1):1\u201315","journal-title":"Cancer Cell Int"},{"issue":"5","key":"10218_CR10","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.3390\/ijms23052642","volume":"23","author":"X Huang","year":"2022","unstructured":"Huang X, Hao J, Tan YQ, Zhu T, Pandey V, Lobie PE (2022) CXC chemokine signaling in progression of epithelial ovarian cancer: Theranostic perspectives. Int J Mol Sci 23(5):2642","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10218_CR11","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3390\/cancers17091547","volume":"17","author":"A Aquino","year":"2025","unstructured":"Aquino A, Franzese O (2025) Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches. Cancers 17(9):1547","journal-title":"Cancers"},{"key":"10218_CR12","doi-asserted-by":"publisher","first-page":"1601756","DOI":"10.3389\/fimmu.2025.1601756","volume":"16","author":"S Babykutty","year":"2025","unstructured":"Babykutty S, XAVIER H, GIREESH GM A, Thomas JA, Suboj P, Biju E et al (2025) Chemokines: humble yet mighty players in the tumour microenvironment. Front Immunol 16:1601756","journal-title":"Front Immunol"},{"issue":"4","key":"10218_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5590","volume":"56","author":"G Camacho Meza","year":"2025","unstructured":"Camacho Meza G, Avalos Navarro G, De La Cruz Mosso U, Ram\u00edrez Pati\u00f1o R, Mu\u00f1oz Valle JF, Bautista Herrera LA (2025) Macrophage migration inhibitory factor: Exploring physiological roles and comparing health benefits against oncogenic and autoimmune risks. Int J Mol Med 56(4):1\u201321","journal-title":"Int J Mol Med"},{"key":"10218_CR14","doi-asserted-by":"publisher","first-page":"1584350","DOI":"10.3389\/fimmu.2025.1584350","volume":"16","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Zhao Z, Lin Z, Fan L, Xiahou Z, Dong Y et al (2025) Decoding multiple myeloma: single-cell insights into tumor heterogeneity, immune dynamics, and disease progression. Front Immunol 16:1584350","journal-title":"Front Immunol"},{"issue":"4","key":"10218_CR15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s12033-024-01133-6","volume":"67","author":"A Mukherjee","year":"2025","unstructured":"Mukherjee A, Abraham S, Singh A, Balaji S, Mukunthan K (2025) From data to cure: A comprehensive exploration of multi-omics data analysis for targeted therapies. Mol Biotechnol 67(4):1269\u20131289","journal-title":"Mol Biotechnol"},{"issue":"4","key":"10218_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/proteomes11040034","volume":"11","author":"T Ivanisevic","year":"2023","unstructured":"Ivanisevic T, Sewduth RN (2023) Multi-omics integration for the design of novel therapies and the identification of novel biomarkers. Proteomes 11(4):34","journal-title":"Proteomes"},{"issue":"11","key":"10218_CR17","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.3390\/ijms25115880","volume":"25","author":"T Matsuoka","year":"2024","unstructured":"Matsuoka T, Yashiro M (2024) Bioinformatics analysis and validation of potential markers associated with prediction and prognosis of gastric cancer. Int J Mol Sci 25(11):5880","journal-title":"Int J Mol Sci"},{"key":"10218_CR18","doi-asserted-by":"crossref","unstructured":"Dharini A, Kejamurthy P, Ramya Devi K (2025) Co-regulation of miRNA and lncRNA on immunosuppression gene: unveiling the regulatory networks in cancer. Nucleosides Nucleotides Nucleic Acids. :1\u201330","DOI":"10.1080\/15257770.2025.2514129"},{"issue":"4","key":"10218_CR19","doi-asserted-by":"publisher","first-page":"100556","DOI":"10.1016\/j.jgeb.2025.100556","volume":"23","author":"S Pandey","year":"2025","unstructured":"Pandey S, Yadav P (2025) Exploring the therapeutic potential of microRNAs: targeted gene regulation strategies for enhanced cancer therapy. J Genetic Eng Biotechnol 23(4):100556","journal-title":"J Genetic Eng Biotechnol"},{"issue":"4","key":"10218_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2017-03-735654","volume":"130","author":"MA Jensen","year":"2017","unstructured":"Jensen MA, Ferretti V, Grossman RL, Staudt LM (2017) The NCI Genomic Data Commons as an engine for precision medicine. Blood 130(4):453\u2013459","journal-title":"Blood"},{"issue":"1","key":"10218_CR21","doi-asserted-by":"publisher","first-page":"180015","DOI":"10.1038\/sdata.2018.15","volume":"5","author":"S Bhattacharya","year":"2018","unstructured":"Bhattacharya S, Dunn P, Thomas CG, Smith B, Schaefer H, Chen J et al (2018) ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. Sci Data 5(1):180015","journal-title":"Sci Data"},{"issue":"Database issue","key":"10218_CR22","doi-asserted-by":"publisher","first-page":"D1228","DOI":"10.1093\/nar\/gks1147","volume":"41","author":"K Breuer","year":"2013","unstructured":"Breuer K, Foroushani AK, Laird MR, Chen C, Sribnaia A, Lo R et al (2013) InnateDB: systems biology of innate immunity and beyond\u2013recent updates and continuing curation. Nucleic Acids Res 41(Database issue):D1228\u2013D1233","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10218_CR23","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1):D638\u2013d46","journal-title":"Nucleic Acids Res"},{"key":"10218_CR24","doi-asserted-by":"crossref","unstructured":"Liu CJ, Hu FF, Xie GY, Miao YR, Li XW, Zeng Y et al (2023) GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. ;24(1)","DOI":"10.1093\/bib\/bbac558"},{"issue":"5","key":"10218_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401\u2013404","journal-title":"Cancer Discov"},{"key":"10218_CR26","doi-asserted-by":"crossref","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife. ;4","DOI":"10.7554\/eLife.05005"},{"issue":"D1","key":"10218_CR27","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X (2020) miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 48(D1):D127\u2013d31","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10218_CR28","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N (2018) miRWalk: An online resource for prediction of microRNA binding sites. PLoS ONE 13(10):e0206239","journal-title":"PLoS ONE"},{"issue":"D1","key":"10218_CR29","doi-asserted-by":"publisher","first-page":"D147","DOI":"10.1093\/nar\/gkae1072","volume":"53","author":"S Cui","year":"2025","unstructured":"Cui S, Yu S, Huang HY, Lin YC, Huang Y, Zhang B et al (2025) miRTarBase 2025: updates to the collection of experimentally validated microRNA-target interactions. Nucleic Acids Res 53(D1):D147\u2013d56","journal-title":"Nucleic Acids Res"},{"key":"10218_CR30","doi-asserted-by":"crossref","unstructured":"Zhu W, Chen Q, Li Y, Wan J, Li J, Tang S (2023) HIF-1\u03b1-Overexpressing Mesenchymal Stem Cells Attenuate Colitis by Regulating M1-like Macrophages Polarization toward M2-like Macrophages. Biomedicines. ;11(3)","DOI":"10.3390\/biomedicines11030825"},{"issue":"46","key":"10218_CR31","doi-asserted-by":"publisher","first-page":"e45739","DOI":"10.1097\/MD.0000000000045739","volume":"104","author":"RH Ma","year":"2025","unstructured":"Ma RH, Luo XB, Liu YP, Li Q (2025) Clonorchis sinensis infection are associated with calcium phosphate gallbladder stones: A single-center retrospective observational study in China. Med (Baltim) 104(46):e45739","journal-title":"Med (Baltim)"},{"key":"10218_CR32","doi-asserted-by":"crossref","unstructured":"Li S-Q, Zhu X-R, Liu Y-Y, Chen M-B (2025) A novel immunological perspective on female-specific cancers: Exploring the signaling pathways of tertiary lymphoid structures and their clinical applications. Life Sci. :123800","DOI":"10.1016\/j.lfs.2025.123800"},{"key":"10218_CR33","unstructured":"Lounici Y (2022) Role of antibody-secreting cells and tertiary lymphoid structures in breast tumors immunosurveillance. Universit\u00e9 de Lyon"},{"issue":"1","key":"10218_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","volume":"9","author":"G-Q Zhu","year":"2023","unstructured":"Zhu G-Q, Tang Z, Huang R, Qu W-F, Fang Y, Yang R et al (2023) CD36\u2009+\u2009cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell discovery 9(1):25","journal-title":"Cell discovery"},{"key":"10218_CR35","doi-asserted-by":"publisher","first-page":"1441081","DOI":"10.3389\/fcell.2024.1441081","volume":"12","author":"H Han","year":"2024","unstructured":"Han H, He T, Wu Y, He T, Zhou W (2024) Multidimensional analysis of tumor stem cells: from biological properties, metabolic adaptations to immune escape mechanisms. Front Cell Dev Biology 12:1441081","journal-title":"Front Cell Dev Biology"},{"issue":"5","key":"10218_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/cas.16371","volume":"116","author":"Y Nagase","year":"2025","unstructured":"Nagase Y, Kodama M, Aimono E, Nakamura K, Takamatsu R, Abe K et al (2025) CXCL9 and CXCL13 shape endometrial cancer immune-activated microenvironment via tertiary lymphoid structure formation. Cancer Sci 116(5):1193\u20131202","journal-title":"Cancer Sci"},{"key":"10218_CR37","doi-asserted-by":"crossref","unstructured":"Mir MA, Javeed T, Ishfaq (2023) CXCL9, CXCL10, CXCL11\/CXCR3 Axis and Immune Activation. Cytokine and Chemokine Networks in Cancer. Springer, pp 271\u2013289","DOI":"10.1007\/978-981-99-4657-0_10"},{"issue":"6","key":"10218_CR38","first-page":"2499","volume":"42","author":"G An","year":"2019","unstructured":"An G, Wu F, Huang S, Feng L, Bai J, Gu S et al (2019) Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor-associated macrophages. Oncol Rep 42(6):2499\u20132511","journal-title":"Oncol Rep"},{"key":"10218_CR39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.33594\/000000809","volume":"59","author":"A Aliyarbayovaa","year":"2025","unstructured":"Aliyarbayovaa A, Sultanovab T, Yaqubovac S, Najafovad T, Sadiqovae G, Salimovaf A (2025) Macrophage Migration Inhibitory Factor: Its Multifaceted Role in Inflammation and Immune Regulation Across Organ Systems. Cell Physiol Biochem 59:569\u2013588","journal-title":"Cell Physiol Biochem"},{"issue":"22","key":"10218_CR40","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.3390\/ijms20225732","volume":"20","author":"P De","year":"2019","unstructured":"De P, Dey N (2019) Mutation-driven signals of ARID1A and PI3K pathways in ovarian carcinomas: alteration is an opportunity. Int J Mol Sci 20(22):5732","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10218_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/biom15010071","volume":"15","author":"K Liu","year":"2025","unstructured":"Liu K, Li Y, Shen M, Xu W, Wu S, Yang X et al (2025) Epigenetic regulation of stromal and immune cells and therapeutic targets in the tumor microenvironment. Biomolecules 15(1):71","journal-title":"Biomolecules"},{"issue":"3","key":"10218_CR42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/cancers13030545","volume":"13","author":"A Mehdi","year":"2021","unstructured":"Mehdi A, Rabbani SA (2021) Role of methylation in pro-and anti-cancer immunity. Cancers 13(3):545","journal-title":"Cancers"},{"issue":"1","key":"10218_CR43","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/j.clbc.2019.08.008","volume":"20","author":"E Razis","year":"2020","unstructured":"Razis E, Kalogeras KT, Kotsantis I, Koliou GA, Manousou K, Wirtz R et al (2020) The Role of CXCL13 and CXCL9 in Early Breast Cancer. Clin Breast Cancer 20(1):e36\u2013e53","journal-title":"Clin Breast Cancer"},{"key":"10218_CR44","doi-asserted-by":"publisher","first-page":"1120562","DOI":"10.3389\/fphar.2023.1120562","volume":"14","author":"M-J Lin","year":"2023","unstructured":"Lin M-J, Tang X-X, Yao G-S, Tan Z-P, Dai L, Wang Y-H et al (2023) A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma. Front Pharmacol 14:1120562","journal-title":"Front Pharmacol"},{"issue":"1","key":"10218_CR45","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s12672-025-02973-7","volume":"16","author":"T Huang","year":"2025","unstructured":"Huang T, Cao R, Gao C, Luo J, Zhou Z, Ma K (2025) Construction and validation of a chemokine-related gene signature associated with prognosis, clinical significance, and immune microenvironment characteristics in cervical cancer. Discover Oncol 16(1):1114","journal-title":"Discover Oncol"},{"issue":"4","key":"10218_CR46","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3892\/etm.2022.11552","volume":"24","author":"Y Li","year":"2022","unstructured":"Li Y, Tan S, Shen Y, Guo L (2022) miR-146a-5p negatively regulates the IL-1\u03b2-stimulated inflammatory response via downregulation of the IRAK1\/TRAF6 signaling pathway in human intestinal epithelial cells. Experimental Therapeutic Med 24(4):615","journal-title":"Experimental Therapeutic Med"},{"issue":"1","key":"10218_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3892\/ijmm.2022.5210","volume":"51","author":"Z Liao","year":"2022","unstructured":"Liao Z, Zheng R, Shao G (2022) Mechanisms and application strategies of miRNA-146a regulating inflammation and fibrosis at molecular and cellular levels. Int J Mol Med 51(1):7","journal-title":"Int J Mol Med"},{"key":"10218_CR48","doi-asserted-by":"crossref","unstructured":"Sanli F, Karatas OF (2025) Understanding miR-200c: an Important Player in Resistance to Cancer Treatment. Adv Ther. :e00238","DOI":"10.1002\/adtp.202500238"},{"issue":"16","key":"10218_CR49","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.3390\/cancers13163996","volume":"13","author":"F Posch","year":"2021","unstructured":"Posch F, Prinz F, Balihodzic A, Mayr C, Kiesslich T, Klec C et al (2021) MiR-200c-3p modulates cisplatin resistance in biliary tract cancer by ZEB1-independent mechanisms. Cancers 13(16):3996","journal-title":"Cancers"},{"key":"10218_CR50","doi-asserted-by":"crossref","unstructured":"Hu W-T, Li M, Ma P-J, Yang D, Liu X-D, Wang Y (2025) A silence catalyst: CCL5-mediated intercellular communication in cancer. Arch Toxicol. :1\u201314","DOI":"10.1007\/s00204-025-04036-w"},{"key":"10218_CR51","doi-asserted-by":"publisher","first-page":"1677363","DOI":"10.3389\/fimmu.2025.1677363","volume":"16","author":"T Wu","year":"2025","unstructured":"Wu T, Liao Y (2025) Roles of tumor-associated macrophages in triple-negative breast cancer progression. Front Immunol 16:1677363","journal-title":"Front Immunol"},{"issue":"17","key":"10218_CR52","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.febslet.2009.07.058","volume":"583","author":"V Schwartz","year":"2009","unstructured":"Schwartz V, Lue H, Kraemer S, Korbiel J, Krohn R, Ohl K et al (2009) A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett 583(17):2749\u20132757","journal-title":"FEBS Lett"},{"key":"10218_CR53","doi-asserted-by":"publisher","first-page":"834731","DOI":"10.3389\/fgene.2022.834731","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu S, Liu Y, Ma H, Fang S, Wei S, Li X et al (2022) A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer. Front Genet 13:834731","journal-title":"Front Genet"},{"key":"10218_CR54","doi-asserted-by":"publisher","first-page":"1325262","DOI":"10.1155\/sci\/1325262","volume":"2025","author":"P Wang","year":"2025","unstructured":"Wang P, Xu S, Guo Q, Zhao Y (2025) Discovery of PAK2 as a Key Regulator of Cancer Stem Cell in Head and Neck Squamous Cell Carcinoma Using Multi-Omic Techniques. Stem Cells Int 2025:1325262","journal-title":"Stem Cells Int"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10218-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-026-10218-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10218-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:03:02Z","timestamp":1775044982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-026-10218-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10218"],"URL":"https:\/\/doi.org\/10.1007\/s00335-026-10218-3","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The use of the laboratory animals was approved by the Standing Committee of Bioethics Research (SCBR) at Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia (Approval no. SCBR-579\/2025). The study was conducted in accordance with the ethical standards outlined in the Declaration of Helsinki and the ARRIVE guidelines. All animal procedures for the xenograft experiments were performed in compliance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, USA), and efforts were made to minimize animal suffering. Nude mice were maintained under pathogen-free conditions with controlled temperature, humidity, and a 12-hour light\u2013dark cycle, with ad libitum access to food and water.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"50"}}